Akademik Veri Yönetim Sistemi
EUROPEAN JOURNAL OF BREAST HEALTH, cilt.16, ss.55-60, 2020 (ESCI İndekslerine Giren Dergi)
Objective: Breast Cancer (BC) is the most frequently diagnosed malignancy worldwide. Not only may BC be associated with rheumatic symptoms and diseases, but also the drugs used in the treatment of this disease, including aromatase inhibitors (AIs), may lead to musculoskeletal system symptoms. In this study, we aimed to investigate the spectrum of rheumatic symptoms and diseases developing in patients with BC having no previous diagnosis of any inflammatory rheumatic disease.